Be part of our Research

News

Censo Biotechnologies to target Chronic Obstructive Pulmonary Disease (COPD)

November 5th 2018

Censo Biotechnologies announce today that it is extending its stem cell based research platform to support the development of treatments for Chronic Obstructive Pulmonary Disease (COPD).

Read
News

Censo Biotechnologies welcomes new Sales and Marketing Graduate

October 22nd 2018

Censo Biotechnologies welcomes new Sales and Marketing Graduate, Kyra Sneddon

Read
News

Censo Biotechnologies check-in to Roslin's Research Hotel

September 26th 2018

Censo Biotechnologies Ltd. (“Censo”), a leader in the creation of induced Pluripotent Stem Cells (iPSCs), is pleased to be one of the first guests to take up accommodation at Roslin Innovation Centre’s novel Research Hotel.

Read
News

Patient-Derived Brain Tumour iPSCs: Models for Investigating Glioma Stemness & Drug Discovery

May 8th 2018

Gliomas are incurable brain cancers. Dysregulated, stem cell-like self-renewal has been implicated in glioma treatment resistance and tumour recurrence. Drugs that eliminate tumour cells possessing this malignant characteristic are urgently needed. It remains, however, an experimental challenge to link heterogeneous glioma genotypes to drug response at scale.

Read
News

Censo Biotechnologies attending Cancer Research UK's inaugural Brain Tumour Conference

April 30th 2018

Cancer Research UK's Brain Tumour Conference will unite the brightest minds in cancer research to discuss and debate some of the greatest issues in the field. The multidisciplinary programme combines expertise from across the breadth of brain tumour research, together with insights from allied disciplines, to spark new opportunities for collaborative research.

Read
News

iPSC-derived Cortical Neuronal High Content Assay

April 17th 2018

Induced pluripotent stem cell (iPSC) technology is used to produce cortical neurons and facilitates physiologically relevant disease modelling and drug discovery. Our poster describes our robust methodology to produce, characterise and assay cortical neurons.

Read
News

The Patient Derived iPSCs for High Grade Glioma (PDi:HGG) project

March 12th 2018

The Patient Derived iPSCs for High Grade Glioma (PDi:HGG) project, supported by Innovate UK and in participation with the University of Leeds, will provide a new strategy for researchers to develop treatments specifically for this cancer.

Read
News

Innovation Recognition for Censo Biotechnologies at SLAS2018

February 1st 2018

Censo Biotechnologies is one of eight companies selected to exhibit on 'Innovation AveNEW' at SLAS2018 in San Diego from 3 - 7 February.

Read
News

Censo Biotechnologies to present at Late Night with LRIG

January 12th 2018

Simon MacKenzie, Chief Business Officer, will be presenting 'Assessing patient population therapeutic response variability using human iPSC derived microglia' at Late Night with LRIG, part of SLAS2018.

Read
News

Censo Biotechnology awarded SMART funding to develop new stem cell technology

November 21st 2017

Censo Biotechnologies Ltd. (“Censo”) announced today that it has been awarded a Scottish Enterprise SMART:SCOTLAND grant to undertake an innovation project that will develop new methods to create stem cells for medical research.

Read
News